ArticleData in brief2018

Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage.

Silvia Bono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.